Loading...

E-Prescribing Market by Component (Solutions and Services), Deployment (On-premise and Cloud), and End User (Hospitals, Office-based Physicians, and Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2019–2026

A01674
Pages: 190
Feb 2020 | 4174 Views
 
Author(s) : Sneha Korad and Makarand Sinnarkar , Vineet Kumar
Tables: 102
Charts: 50
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the E-prescribing Market

Request Now !

Electronic Prescribing (E-prescribing) Market Statistics - 2026

The e-prescribing market size was valued at $885.6 million in 2018, and is projected to reach $4,152.7 million by 2026, growing at a CAGR of 21.4% from 2019 to 2026. E-prescribing is an application that sends patients or end users prescriptions electronically from their computer to chosen pharmacies. The primary goal of e-prescribing models in an EHR or HIT systems are efficient transmission and receipt of complete, accurate, and unambiguous prescription orders that help optimize pharmacy processing and fulfillment, thereby eliminating disruptions in workflow and delays in patient care. 

Electronic Prescribing (E-prescribing) solutions are widely adopted among healthcare industry due to its benefits such as improved patient safety, fewer medication errors due to handwritten prescriptions, fewer medication errors due to misunderstood phoned-in prescriptions, and less risk of lost or misplaced written prescriptions. This in turn is expected to boost growth of the global e-prescribing market during the forecast period.

E-Prescribing Market Infographics

Get more information on this report : Request Sample Pages

 

The hospital segment registered high revenue growth in 2018 among all the segments in the global e-prescribing market and is expected to continue this trend over the coming years. This is attributed to rise in adoption of electronic prescribing and medication administration systems with benefits such as accurate communication among healthcare professional and reduced adverse drug events, medication errors, and healthcare costs.

E-Prescribing Market
By Component

Your browser does not support the canvas element.

Solutions is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

North America has garnered high revenue share due to high adoption of e-prescription integrated systems and increase in adoption toward advanced healthcare technology products. This is a major factor to drive the growth of the e-prescribing market forecast. Moreover, as individuals in the region are inclining toward patient-centric solutions, the adoption of e-prescribing is helping physicians in the region to provide exquisite experience without the need to invest in time for visiting the hospital in non-emergence situations. Whereas, the ambulatory care institutes in the region have adopted e-prescribing solutions at a significant rate due to favorable government initiative toward public safety. Aforementioned are factors that support the e-prescribing market growth in the North America region. 

E-Prescribing Market
By Deployment

Your browser does not support the canvas element.

Web and Cloud-based is projected as one of the most significant segments.

Get more information on this report : Request Sample Pages

The report focuses on the growth prospects, restraints, and market analysis. The study provides Porter’s five forces analysis of the e-prescribing industry to understand the impact of various factors such as bargaining power of suppliers, competitive intensity of competitors, threat of new entrants, threat of substitutes, and bargaining power of buyers on the electronic prescribing market.

E-Prescribing Market
By Application

Your browser does not support the canvas element.

Hospitals is projected as one of the most significant segments.

Get more information on this report : Request Sample Pages

Segment review

The e-prescribing market segmentation is based on component, deployment, end user, and region. By component, it is categorized into solutions and services. On the basis of deployment, it is divided on-premise and cloud. Depending on end user, it is classified into hospitals, office-based physicians, and pharmaceuticals. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

E-Prescribing Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 24.3% during 2019-2026.

Get more information on this report : Request Sample Pages

Key players operating in the global e-prescribing market analysis include Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts.

Top impacting factors    

The global e-prescribing market is influenced by several factors among which favorable government initiatives and incentive programs have gained high traction and has significantly impacted the growth of the market. Moreover, rise in focus on the reduction of fraud and abuse of controlled substances among healthcare institutions and need to curtail escalating healthcare costs are among some of the major factors to drive growth of the market in the coming years. However, concerns associated with electronic health record (EHR) data security and complex workflow issues associated with integration e-prescribing into existing systems are factors that restrain the market growth to a certain extent. Furthermore, Asia-Pacific countries are expected to garner high adoption rate of e-prescribing owing to on-going healthcare infrastructure development activities, which supports technological advancements in the existing systems, 

Government initiatives and incentive programs

Initial government initiatives were primarily focused on the integration of technology into healthcare sector to ease patient waiting time and service delivery. Advent of technological transformation in healthcare shifted this focus towards standardizing the fragmented technological advance approaches among which development of standards for e-prescribing systems and implementation gained high momentum from the past decade. Aforementioned is a factor that drive the e-prescribing market trends during the forecast period. For example, in 2011, the U.S. Centers for Medicare & Medicaid Services established the Medicare and Medicaid EHR Incentive Programs, which encouraged eligible hospitals & critical access hospitals, and clinicians to implement, upgrade (AIU), demonstrate, and adopt the advance Certified EHR Technology (CEHRT).

Rise in focus on the reduction of fraud and abuse of controlled substances

E-prescribing solutions haves been evaluated to have the potential to improve efficiency by streamlining clinical practice workflow throughout the healthcare systems. In addition, these systems have also advanced to improve patient satisfaction with digital care by reducing wait-time at the pharmacy, improved patient compliance, and reduced the cost of medication to patients by automatically recommending cost-effective generics and preferred formulations. Aforementioned features are key indicators that haves supported the growth of the market and is expected to further garner high revenue growth in the coming years

Key Benefits for Stakeholders:

  • This study includes the e-prescribing market opportunity, analysis, trends, and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities of the e-prescribing industry.
  • The e-prescribing market share is quantitatively analyzed from 2018 to 2026 to highlight the financial competency of the industry.
  • Porter’s five forces analysis illustrates the potency of the buyers & suppliers in the e-prescribing market.

Key Market Segments:

By Component

  • Solutions 
  • Services

By Deployment

  • On-premise
  • Cloud

By End User

  • Hospitals
  • Office-based Physicians
  • Pharmaceuticals

By Region

  • North America
    • U.S.
    • Canada
  • Europe 
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific 
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America 
    • Middle East
    • Africa

Key Market Players

  • Allscripts Healthcare, LLC
  • Athenahealth, Inc.
  • Cerner Corporation
  • Change Healthcare
  • DrFirst.com, Inc.
  • eClinicalWorks
  • Epic Systems Corporation
  • Medical Information Technology, Inc.
  • Practice Fusion, Inc. 
  • Surescripts
 

CHAPTER 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. KEY MARKET PLAYERS
1.5. RESEARCH METHODOLOGY

1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS

2.1.1. Top impacting factors
2.1.2. Top investment pockets

2.2. CXO PERSPECTIVE

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FORCES SHAPING THE GLOBAL E-PRESCRIBING MARKET
3.3. VALUE CHAIN ANALYSIS
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Government initiatives and incentive programs
3.4.1.2. Rise in focus on the reduction of fraud and abuse of controlled substances
3.4.1.3. Need to curtail escalating healthcare costs

3.4.2. Restraints

3.4.2.1. High cost of systems
3.4.2.2. Security & workflow issues

3.4.3. Opportunities

3.4.3.1. Growth in the developing countries across Asia-Pacific

3.5. INDUSTRY ROADMAP OF E-PRESCRIBING
3.6. IMPACT OF GOVERNMENT REGULATIONS ON THE GLOBAL E-PRESCRIBING MARKET

CHAPTER 4: E-PRESCRIBING MARKET, BY COMPONENT

4.1. OVERVIEW
4.2. SOLUTIONS

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. SERVICES

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: E-PRESCRIBING MARKET, BY DEPLOYMENT

5.1. OVERVIEW
5.2. WEB & CLOUD-BASED

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country

5.3. ON-PREMISE

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country

CHAPTER 6: E-PRESCRIBING MARKET, BY END USER

6.1. OVERVIEW
6.2. HOSPITALS

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country

6.3. OFFICE-BASED PHYSICIANS

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country

6.4. PHARMACEUTICALS

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country

CHAPTER 7: E-PRESCRIBING MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast, by region

7.2. NORTH AMERICA

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by component
7.2.3. Market size and forecast, by deployment
7.2.4. Market size and forecast, by end user
7.2.5. Market analysis, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by component
7.2.5.1.2. Market size and forecast, by deployment
7.2.5.1.3. Market size and forecast, by end user

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by component
7.2.5.2.2. Market size and forecast, by deployment
7.2.5.2.3. Market size and forecast, by end user

7.3. EUROPE

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by component
7.3.3. Market size and forecast, by deployment
7.3.4. Market size and forecast, by end user
7.3.5. Market analysis, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by component
7.3.5.1.2. Market size and forecast, by deployment

7.3.5.1.3. Market size and forecast, by end user

7.3.5.2. UK

7.3.5.2.1. Market size and forecast, by component
7.3.5.2.2. Market size and forecast, by deployment
7.3.5.2.3. Market size and forecast, by end user

7.3.5.3. France

7.3.5.3.1. Market size and forecast, by component
7.3.5.3.2. Market size and forecast, by deployment
7.3.5.3.3. Market size and forecast, by end user

7.3.5.4. Rest of Europe

7.3.5.4.1. Market size and forecast, by component
7.3.5.4.2. Market size and forecast, by deployment
7.3.5.4.3. Market size and forecast, by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by component
7.4.3. Market size and forecast, by deployment
7.4.4. Market size and forecast, by end user
7.4.5. Market analysis, by country

7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by component
7.4.5.1.2. Market size and forecast, by deployment
7.4.5.1.3. Market size and forecast, by end user

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by component
7.4.5.2.2. Market size and forecast, by deployment
7.4.5.2.3. Market size and forecast, by end user

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by component
7.4.5.3.2. Market size and forecast, by deployment
7.4.5.3.3. Market size and forecast, by end user

7.4.5.4. Rest of Asia-Pacific

7.4.5.4.1. Market size and forecast, by component
7.4.5.4.2. Market size and forecast, by deployment
7.4.5.4.3. Market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by component
7.5.3. Market size and forecast, by deployment
7.5.4. Market size and forecast, by end user
7.5.5. Market analysis, by country

7.5.5.1. Latin America

7.5.5.1.1. Market size and forecast, by component
7.5.5.1.2. Market size and forecast, by deployment
7.5.5.1.3. Market size and forecast, by end user

7.5.5.2. Middle East

7.5.5.2.1. Market size and forecast, by component
7.5.5.2.2. Market size and forecast, by deployment
7.5.5.2.3. Market size and forecast, by end user

7.5.5.3. Africa

7.5.5.3.1. Market size and forecast, by component
7.5.5.3.2. Market size and forecast, by deployment
7.5.5.3.3. Market size and forecast, by end user

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. KEY PLAYERS POSITIONING ANALYSIS, 2018
8.2. TOP WINNING STRATEGIES
8.3. KEY DEVELOPMENTS

8.3.1. Product launches
8.3.2. Partnership
8.3.3. Business expansion
8.3.4. Acquisition
8.3.5. Collaboration

8.4. PATENT ANALYSIS

8.4.1. By region (2016-2019)
8.4.2. By applicant

CHAPTER 9: COMPANY PROFILE

9.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments

9.2. ATHENAHEALTH, INC.

9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments

9.3. CERNER CORPORATION

9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. CHANGE HEALTHCARE

9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments

9.5. DRFIRST

9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Product portfolio
9.5.5. Key strategic moves and developments

9.6. ECLINICALWORKS

9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments

9.7. EPIC SYSTEMS CORPORATION

9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments

9.8. MEDICAL INFORMATION TECHNOLOGY, INC.

9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.8.5. Key strategic moves and developments

9.9. PRACTICE FUSION, INC.

9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Key strategic moves and developments

9.10. SURESCRIPTS

9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018-2026 ($MILLION)
TABLE 02. E-PRESCRIBING MARKET REVENUE FOR SOLUTIONS, BY REGION 2018–2026 ($MILLION)
TABLE 03. E-PRESCRIBING MARKET REVENUE FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 05. E-PRESCRIBING MARKET REVENUE FOR WEB & CLOUD-BASED, BY REGION  2018–2026 ($MILLION)
TABLE 06. E-PRESCRIBING MARKET REVENUE FOR ON-PREMISE, BY REGION 2018–2026 ($MILLION)
TABLE 07. GLOBAL E-PRESCRIBING MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. E-PRESCRIBING MARKET REVENUE FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. E-PRESCRIBING MARKET REVENUE FOR OFFICE-BASED PHYSICIANS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. E-PRESCRIBING MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 15. NORTH AMERICA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16. U.S. E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 17. U.S. E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 18. U.S. E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 19. CANADA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 20. CANADA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 21. CANADA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 22. EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 23. EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 24. EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 25. EUROPE E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 26. GERMANY E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 27. GERMANY E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 28. GERMANY E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 29. UK E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 30. UK E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 31. UK E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 32. FRANCE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 33. FRANCE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 34. FRANCE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 35. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 36. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 37. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 38. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 39. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 40. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 41. ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 42. JAPAN E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 43. JAPAN E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 44. JAPAN E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 45. CHINA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 46. CHINA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 47. CHINA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 48. INDIA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 49. INDIA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 50. INDIA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 55. LAMEA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT 2018–2026 ($MILLION)
TABLE 56. LAMEA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 57. LAMEA E-PRESCRIBING MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 58. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 59. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 60. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 61. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 62. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 63. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 64. AFRICA E-PRESCRIBING MARKET REVENUE, BY COMPONENT, 2018–2026 ($MILLION)
TABLE 65. AFRICA E-PRESCRIBING MARKET REVENUE, BY DEPLOYMENT, 2018–2026 ($MILLION)
TABLE 66. AFRICA E-PRESCRIBING MARKET REVENUE, BY END USER 2018–2026 ($MILLION)
TABLE 67. KEY NEW PRODUCT LAUNCHES (2016-2019)
TABLE 68. PARTNERSHIP (2016-2019)
TABLE 69. KEY EXPANSION (2016-2019)
TABLE 70. KEY ACQUISITION (2016-2019)
TABLE 71. COLLABORATION (2016-2019)
TABLE 72. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 73. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 74. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: OPERATING SEGMENTS
TABLE 75. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 76. ATHENAHEALTH, INC.: KEY EXECUTIVES
TABLE 77. ATHENAHEALTH, INC.: COMPANY SNAPSHOT
TABLE 78. ATHENAHEALTH, INC.: PRODUCT PORTFOLIO
TABLE 79. CERNER CORPORATION: KEY EXECUTIVES
TABLE 80. CERNER CORPORATION: COMPANY SNAPSHOT
TABLE 81. CERNER CORPORATION: PRODUCT PORTFOLIO
TABLE 82. CHANGE HEALTHCARE: KEY EXECUTIVES
TABLE 83. CHANGE HEALTHCARE: COMPANY SNAPSHOT
TABLE 84. CHANGE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85. DRFIRST: KEY EXECUTIVES
TABLE 86. DRFIRST: COMPANY SNAPSHOT
TABLE 87. DRFIRST: PRODUCT PORTFOLIO
TABLE 88. ECLINICALWORKS: KEY EXECUTIVES
TABLE 89. ECLINICALWORKS: COMPANY SNAPSHOT
TABLE 90. ECLINICALWORKS: PRODUCT PORTFOLIO
TABLE 91. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 92. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 93. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 94. MEDICAL INFORMATION TECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 95. MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 96. MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 97. PRACTICE FUSION, INC.: KEY EXECUTIVES
TABLE 98. PRACTICE FUSION, INC.: COMPANY SNAPSHOT
TABLE 99. PRACTICE FUSION, INC.: PRODUCT PORTFOLIO
TABLE 100. SURESCRIPTS: KEY EXECUTIVES
TABLE 101. SURESCRIPTS: COMPANY SNAPSHOT
TABLE 102. SURESCRIPTS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL E-PRESCRIBING MARKET, 2018–2026
FIGURE 03. GLOBAL E-PRESCRIBING MARKET, BY REGION, 2018–2026
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYERS OF THE GLOBAL E-PRESCRIBING MARKET
FIGURE 07. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE-TO-HIGH BARGAINING POWER OF BUYER
FIGURE 09. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. LOW-TO-HIGH COMPETITIVE RIVALRY
FIGURE 12. VALUE CHAIN ANALYSIS OF E-PRESCRIBING MARKET
FIGURE 13. MARKET DYNAMICS: GLOBAL E-PRESCRIBING MARKET
FIGURE 14. INDUSTRY ROADMAP OF E-PRESCRIBING
FIGURE 15. GLOBAL E-PRESCRIBING MARKET, BY COMPONENT, 2018-2026
FIGURE 16. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SOLUTIONS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. GLOBAL E-PRESCRIBING MARKET, BY DEPLOYMENT, 2018–2025
FIGURE 19. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR WEB & CLOUD-BASED, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS GLOBAL E-PRESCRIBING MARKET FOR ON-PREMISE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 21. GLOBAL E-PRESCRIBING MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR OFFICE-BASED PHYSICIANS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLOBAL E-PRESCRIBING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25. GLOBAL E-PRESCRIBING MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
FIGURE 26. U.S. E-PRESCRIBING MARKET REVENUE, 2018–2026 ($MILLION)
FIGURE 27. CANADA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 28. GERMANY E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 29. UK E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 30. FRANCE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 31. REST OF EUROPE E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 32. JAPAN E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 33. CHINA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 34. INDIA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 36. LATIN AMERICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 37. MIDDLE EAST E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 38. AFRICA E-PRESCRIBING MARKET REVENUE, 2018-2026 ($MILLION)
FIGURE 39. KEY PLAYER POSITIONING ANLYSIS: GLOBAL E-PRESCRIBING MARKET
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2016-2019
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2016-2019
FIGURE 43. PATENT ANALYSIS, BY REGION
FIGURE 44. PATENT ANALYSIS, BY APPLICANT
FIGURE 45. R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 46. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE, 2016–2018 ($MILLION)
FIGURE 47. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. CERNER CORPORATION: REVENUE, 2016–2018 ($MILLION)
FIGURE 50. CERNER CORPORATION: REVENUE SHARE BY REGION, 2018 (%)

 
 

Healthcare systems have evolved to health information technology (HIT) systems that leverage technology aspects to enable greater cost savings, efficiency, and eventually improved patient outcomes. Encouraged by managed care pharmacists, e-prescribing modules are being significantly integrated with electronic health record systems (EHR) and has been identified benefits over paper prescribing approach. Hence, major managed care organizations such as health maintenance organizations (HMO) and preferred provider organization (PPO) has initiated computerized prescribing by distributing personal digital assistants (PDAs) with their formulary added as a built-in feature for doctors.

Potential benefits of e-prescribing have been leveraged by prescribers, pharmacies, payers, and patients. Majorly, the benefits associated with e-prescribing is categorized into safety, improved prescribing efficiency or workflow, and cost savings. Thus, high adoption of HER systems with e-prescribing has garnered high momentum, which in turn is expected to drive the growth of the market in the coming years.   

The global e-prescribing market in Asia-Pacific is expected to anticipate significant opportunities as countries in the region are focused toward digitalizing their IT & healthcare infrastructure. In addition, healthcare industry in the Asia-Pacific is expected to garner high adoption of e-prescribing EHR systems to manage high number of patients, to reduce patient turnaround time, and improve service quality in emergency departments.

Moreover, North America countries have anticipated high revenue growth and is expected to remain dominant during the forecast period. The growth of market in North America is attributed to be well-developed healthcare infrastructure, which has helped easy adoption of e-prescribing into existing HER or HIS systems.

The key players operating in the global e-prescribing market include Allscripts Healthcare, LLC, Athenahealth, Inc., Cerner Corporation, Change Healthcare, DrFirst.com, Inc., eClinicalWorks, Epic Systems Corporation, Medical Information Technology, Inc., Practice Fusion, Inc., and Surescripts. Majority of the players in the market have adopted various revenue and business growth strategies to enhance and develop their product portfolio, strengthen their e-prescribing market share, and help them to increase their market penetration.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
E-Prescribing Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts